Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (unaudited)

v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (unaudited) - USD ($)
Common Shares
Additional Paid-in Capital
Accumulated Deficit
ASC842 adoption adjustment
Accumulated Deficit
ASC842 adoption adjustment
Total
Balance at Dec. 31, 2021 $ 2,000 $ 228,578,000   $ (212,203,000)   $ 16,377,000
Balance (in shares) at Dec. 31, 2021 158,191          
Stock-based compensation   480,000       480,000
Stock-based compensation (in shares) 10,674          
Release of vested restricted common stock (in shares) 57          
Restricted stock awards cancelled (in shares) (87)          
Net loss       (3,904,000)   (3,904,000)
Balance at Mar. 31, 2022 $ 2,000 229,058,000 $ 33,000 (216,074,000) $ 33,000 12,986,000
Balance (in shares) at Mar. 31, 2022 168,835          
Balance at Dec. 31, 2021 $ 2,000 228,578,000   (212,203,000)   16,377,000
Balance (in shares) at Dec. 31, 2021 158,191          
Net loss           (12,661,000)
Balance at Sep. 30, 2022 $ 2,000 230,181,000   (224,831,000)   5,352,000
Balance (in shares) at Sep. 30, 2022 171,194          
Balance at Dec. 31, 2021 $ 2,000 228,578,000   (212,203,000)   16,377,000
Balance (in shares) at Dec. 31, 2021 158,191          
Balance at Dec. 31, 2022 $ 7,000 226,318,000   (228,321,000)   (1,996,000) [1]
Balance (in shares) at Dec. 31, 2022 712,564          
Balance at Mar. 31, 2022 $ 2,000 229,058,000 $ 33,000 (216,074,000) $ 33,000 12,986,000
Balance (in shares) at Mar. 31, 2022 168,835          
Stock-based compensation   506,000       506,000
Stock-based compensation (in shares) 300          
Release of vested restricted common stock (in shares) 12          
Restricted stock awards cancelled (in shares) (148)          
Net loss       (4,108,000)   (4,108,000)
Balance at Jun. 30, 2022 $ 2,000 229,564,000   (220,182,000)   9,384,000
Balance (in shares) at Jun. 30, 2022 168,999          
Stock-based compensation   526,000       526,000
Stock-based compensation (in shares) 1,775          
Release of vested restricted common stock (in shares) 599          
Restricted stock awards cancelled (in shares) (179)          
Issuance of warrants in connection with convertible promissory note   91,000       91,000
Net loss       (4,649,000)   (4,649,000)
Balance at Sep. 30, 2022 $ 2,000 230,181,000   (224,831,000)   5,352,000
Balance (in shares) at Sep. 30, 2022 171,194          
Balance at Dec. 31, 2022 $ 7,000 226,318,000   (228,321,000)   (1,996,000) [1]
Balance (in shares) at Dec. 31, 2022 712,564          
Issuance of common stock in connection with warrant exercise   8,202,000       8,202,000
Issuance of common stock in connection with warrant exercise (in shares) 858,353          
Stock-based compensation   499,000       499,000
Restricted stock awards cancelled (in shares) (43)          
Issuance of common stock in connection with convertible promissory note   708,000       708,000
Issuance of common stock in connection with convertible promissory note (In shares) 67,500          
Issuance of common stock and warrants, net of offering costs   1,271,000       1,271,000
Issuance of common stock and warrants, net of offering costs (in shares) 1,420,513          
Net loss       (921,000)   (921,000)
Balance at Mar. 31, 2023 $ 7,000 236,998,000   (229,242,000)   7,763,000
Balance (in shares) at Mar. 31, 2023 3,058,887          
Balance at Dec. 31, 2022 $ 7,000 226,318,000   (228,321,000)   (1,996,000) [1]
Balance (in shares) at Dec. 31, 2022 712,564          
Net loss           (12,358,000)
Balance at Sep. 30, 2023 $ 7,000 241,557,000   (240,679,000)   885,000
Balance (in shares) at Sep. 30, 2023 6,579,957          
Balance at Mar. 31, 2023 $ 7,000 236,998,000   (229,242,000)   7,763,000
Balance (in shares) at Mar. 31, 2023 3,058,887          
Issuance of common stock in connection with warrant exercise   1,895,000       1,895,000
Issuance of common stock in connection with warrant exercise (in shares) 1,486,132          
Stock-based compensation   481,000       481,000
Release of vested restricted common stock (in shares) 71          
Restricted stock awards cancelled (in shares) (96)          
Issuance of common stock and warrants, net of offering costs   1,048,000       1,048,000
Issuance of common stock and warrants, net of offering costs (in shares) 755,922          
Net loss       (5,326,000)   (5,326,000)
Balance at Jun. 30, 2023 $ 7,000 240,422,000   (234,568,000)   5,861,000
Balance (in shares) at Jun. 30, 2023 5,300,916          
Issuance of common stock in connection with warrant exercise   617,000       617,000
Issuance of common stock in connection with warrant exercise (in shares) 510,000          
Stock-based compensation   518,000       518,000
Stock-based compensation (in shares) 769,041          
Net loss       (6,111,000)   (6,111,000)
Balance at Sep. 30, 2023 $ 7,000 $ 241,557,000   $ (240,679,000)   $ 885,000
Balance (in shares) at Sep. 30, 2023 6,579,957          
[1] The condensed consolidated balance sheet as of December 31, 2022 was derived from the audited consolidated balance sheet as of that date.